These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6320704)

  • 1. [Receptor structural study of BHK 21 cells interacting with the vesicular stomatitis virus].
    Seganti L; Mastromarino P; Superti F; Grippa E; Orsi N
    Ann Ist Super Sanita; 1982; 18(3):385-8. PubMed ID: 6320704
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of carbohydrates in cell membrane receptors for vesicular stomatitis virus.
    Seganti L; Superti F; Mastromarino P; Sinibaldi L; Orsi N
    Boll Ist Sieroter Milan; 1982; 61(4):294-9. PubMed ID: 6100232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of human serum lipoproteins on the infectivity of rhabdoviruses.
    Seganti L; Grassi M; Mastromarino P; Panà A; Superti F; Orsi N
    Microbiologica; 1983 Apr; 6(2):91-9. PubMed ID: 6306404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gangliosides in early interactions between vesicular stomatitis virus and CER cells.
    Sinibaldi L; Goldoni P; Seganti L; Superti F; Tsiang H; Orsi N
    Microbiologica; 1985 Oct; 8(4):355-65. PubMed ID: 2999565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptability costs in immune escape variants of vesicular stomatitis virus.
    Novella IS; Gilbertson DL; Borrego B; Domingo E; Holland JJ
    Virus Res; 2005 Jan; 107(1):27-34. PubMed ID: 15567030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of plant lectins on polykaryocyte formation by vesicular stomatitis virus in BHK-21 cells.
    Takehara M
    Microbiol Immunol; 1979; 23(9):921-5. PubMed ID: 231732
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
    Korutla L; Kumar R
    Biochem Biophys Res Commun; 1996 Mar; 220(3):670-4. PubMed ID: 8607823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components.
    Brown F; Cartwright B; Almeida JD
    J Immunol; 1966 Mar; 96(3):537-45. PubMed ID: 4286685
    [No Abstract]   [Full Text] [Related]  

  • 9. Electron microscopic study of development of vesicular stomatitis virus using ferritin-labelled antibodies.
    Coward JE; Harter DH; Hsu KC; Morgan C
    J Gen Virol; 1971 Oct; 13(1):27-34. PubMed ID: 4108672
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of sialic acid in infection with vesicular stomatitis virus.
    Cartwright B; Brown F
    J Gen Virol; 1977 Apr; 35(1):197-9. PubMed ID: 192844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular distribution of swine vesicular disease virus proteins and alterations induced in infected cells: a comparative study with foot-and-mouth disease virus and vesicular stomatitis virus.
    Martín-Acebes MA; González-Magaldi M; Rosas MF; Borrego B; Brocchi E; Armas-Portela R; Sobrino F
    Virology; 2008 May; 374(2):432-43. PubMed ID: 18279902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished virucidal activity of kethoxal against vesicular stomatitis virus pretreated with guanidinating reagent and proteases.
    Sabina LR; Morrow DG; Szabo RA
    Acta Virol; 1976 Apr; 20(2):119-25. PubMed ID: 5866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of antivirus activity of mineral condensed polyanions. II. Effect on vesicular stomatitis virus.
    Raybaud N; Jasmin C; Huppert J; Chermann JC; Mathé G; Raynaud M
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):295-9. PubMed ID: 4340879
    [No Abstract]   [Full Text] [Related]  

  • 14. Two haemagglutinating components of vesicular stomatitis virus.
    Arstila P
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(1):33-40. PubMed ID: 4336304
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for a host cell component in vesicular stomatitis virus.
    Cartwright B; Pearce CA
    J Gen Virol; 1968 Mar; 2(2):207-14. PubMed ID: 4297603
    [No Abstract]   [Full Text] [Related]  

  • 16. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activities of silver sulfadiazine in ocular infection.
    Tokumaru T; Shimizu Y; Fox CL
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):151-8. PubMed ID: 4368031
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of vesicular stomatitis virus infection in the infant hamster and mouse.
    Bruno-Lobo M; Peralta PH; Bruno-Lobo GG; de Paola D
    An Microbiol (Rio J); 1968; 15():53-68. PubMed ID: 4316894
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells.
    Romanutti C; Castilla V; Coto CE; Wachsman MB
    Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.